SCHEMBL9434368

SCHEMBL9434368

CCOC(=O)C1=Nc2cc3c(c(C)c2=C1C)N=c1ccc(Br)cc1=3

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.36
ALDH1A1 P00352 1/20 0.36
GABRA1 P14867 1/20 0.35
GABRB1 P18505 1/20 0.35
GABRA3 P34903 1/20 0.35
GABRB2 P47870 1/20 0.35
MAPT P10636 5/20 0.34
HTT P42858 2/20 0.34
LMNA P02545 2/20 0.34
HSP90AA1 P07900 1/20 0.34
HIF1A Q16665 1/20 0.34
FGB P02675 1/20 0.33
ELANE P08246 2/20 0.33
TARBP2 Q15633 1/20 0.32
MAPK1 P28482 1/20 0.32
SLC5A1 P13866 1/20 0.32
SLC5A2 P31639 1/20 0.32
ATM Q13315 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9434910 0.86 HRH3 (0.37) SMN1; SMN2ALDH1A1MAPTHTTLMNA
SCHEMBL8150303 0.85 MAPT (0.41) SMN1; SMN2ALDH1A1GABRA1GABRB1GABRA3
SCHEMBL9434110 0.84 SMN1; SMN2 (0.36) SMN1; SMN2ALDH1A1GABRA1GABRA3MAPT
SCHEMBL9434365 0.78 FGB (0.42) SMN1; SMN2ALDH1A1MAPTHTTLMNA
SCHEMBL1388444 0.77 FGB (0.38) SMN1; SMN2ALDH1A1MAPTHTTLMNA
SCHEMBL9435000 0.74 MAPT (0.32) MAPTMEN1KMT2AKDM4E
SCHEMBL8150574 0.73 LMNA (0.30) SMN1; SMN2MAPTHTTLMNAHSP90AA1
SCHEMBL8155848 0.72 PDE1C (0.36) SMN1; SMN2MAPTMEN1KMT2A
SCHEMBL9435019 0.71 ALDH1A1 (0.35) SMN1; SMN2ALDH1A1MAPTHTTLMNA
SCHEMBL7963227 0.70 LMNA (0.36) SMN1; SMN2ALDH1A1MAPTHTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1994002483-A1 TETRACYCLIC COMPOUNDS PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOUR AGENTS THE WELLCOME FOUNDATION LIMITED (GB) 1994-02-03 WO disclosed